Next Article in Journal
Nasal Nanovaccines for SARS-CoV-2 to Address COVID-19
Previous Article in Journal
Toward a Multivalent Synthetic Oligosaccharide-Based Conjugate Vaccine against Shigella: State-of-the-Art for a Monovalent Prototype and Challenges
 
 
Article

Article Versions Notes

Vaccines 2022, 10(3), 404; https://doi.org/10.3390/vaccines10030404
Action Date Notes Link
article pdf uploaded. 7 March 2022 15:42 CET Version of Record https://www.mdpi.com/2076-393X/10/3/404/pdf-vor
article supplementary file uploaded. 7 March 2022 15:42 CET - https://www.mdpi.com/2076-393X/10/3/404#supplementary
article xml file uploaded 8 March 2022 11:16 CET Original file -
article xml uploaded. 8 March 2022 11:16 CET Update https://www.mdpi.com/2076-393X/10/3/404/xml
article pdf uploaded. 8 March 2022 11:16 CET Updated version of record https://www.mdpi.com/2076-393X/10/3/404/pdf
article html file updated 8 March 2022 11:17 CET Original file -
article html file updated 1 August 2022 04:31 CEST Update https://www.mdpi.com/2076-393X/10/3/404/html
Back to TopTop